Gilead’s Descovy got a green light from an FDA advisory committee for HIV pre-exposure prophylaxis (PrEP) yesterday – but as expected its use in women was a point of contention. Descovy ...

Gilead Sciences’ Descovy, its successor to HIV pre-exposure prophylaxis (PrEP) therapy Truvada, is heading into an FDA advisory committee meeting on Wednesday with a mostly-positive verdict from ...

Specifically, Descovy is taken by adults and certain children for the following uses: to treat HIV as preexposure prophylaxis (PrEP) to help prevent HIV The active ingredients in Descovy are ...

PrEP is a medication that helps reduce the risk of HIV before exposure. It’s recommended for people at high risk of contracting HIV from sexual contact or injection drug use. Descovy is approved ...

Specifically, Descovy is used in adults and some children: to help prevent HIV, also known as preexposure prophylaxis (PrEP), in people who have an increased risk of contracting HIV to treat HIV ...

These options include two, once-daily oral medications called Truvada (generic versions available), and Descovy. The third option is a long-acting injectable ... or while breastfeeding. Most ...